Humana (HUM)

Humana plans more Medicare Advantage plan exits in 2027 as it targets a 3% margin and reshapes its portfolio.

UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.

Analysts change outlook on top names, including PAY, MAS, FVRR, HUM, and SITE. See their ratings and price targets on Benzinga's analyst ratings page.

Humana (NYSE:HUM) said its 2026 performance is tracking in line with expectations, with management emphasizing planned Medicare Advantage margin expansion in 2027, progress in its Stars program and continued operating-cost reductions as key components of its path toward a sustainable pretax margin o

What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earn...

HUM stock drops premarket: Humana beats Q2 estimates, but fails to impress as industry peers raise expectations.

GE HealthCare is among S&P 500 leaders and Humana among the laggards after both beat Q2 forecasts. Both stocks are near key levels.

Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-G...

Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM

Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know. Humana met analy...

Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care. Chief Executive Officer Ted Wahl said the company

UNH stock surged past a buy point, leading the Dow Jones, after Q2 earnings trounced estimates amid lower-than-expected benefit costs.

Top healthcare insurance stocks like UNH, CVS, and Humana stocks are rising after the Medicare advantage payment hike and analysts are taking note.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:H...

The "Mad Money" host says, "Buy it." Should you listen?

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...